Jean-Baptiste Bachet

17PUBLICATIONS
126CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 03, 2026
Impact of Tumor Genomic Profile on Adjuvant Chemotherapy Efficacy in Resected Pancreatic Adenocarcinoma: Results From the PRODIGE-24/CCTG PA6 Study.

|Jul 27, 2026
Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.

|Apr 22, 2026
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer.

|Nov 04, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.

Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade

|Oct 06, 2025
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi).

Marine Valery, Julien Edeline, Julie Henriques

|Aug 13, 2025
FedECA: federated external control arms for causal inference with time-to-event data in distributed settings.

Jean Ogier du Terrail, Quentin Klopfenstein, Honghao Li

Pageof 3

Frequent Collaborators

6 joint publications

Julien Taieb

5 joint publications

Jerome Cros

3 joint publications

Anthony Turpin

3 joint publications

Laetitia Dahan